Selvita S.A. Logo

Selvita S.A.

Preclinical CRO offering integrated drug discovery and development services for life sciences.

SLV | WAR

Overview

Corporate Details

ISIN(s):
PLSLVCR00029 (+1 more)
LEI:
25940057WQ9YP5MOQF28
Country:
Poland
Address:
KRAKÓW PODOLE 79, 30-394 KRAKÓW
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Selvita S.A. is one of Europe's largest preclinical Contract Research Organizations (CROs), providing integrated services for the pharmaceutical, biopharmaceutical, and chemical industries. The company specializes in drug discovery and development, with a mission to bridge the gap between early discovery and the clinical stages. Selvita offers a comprehensive scope of solutions, including high-quality research and development support and advanced analytical services. It supports client projects across various therapeutic areas, helping to accelerate the development of new therapies for patients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 19:13
Regulatory News Service
Otrzymanie zlecenia w ramach istotnej współpracy / Receipt of an Order as Part …
English 2.4 KB
2025-11-27 19:13
Regulatory News Service
Otrzymanie zlecenia w ramach istotnej współpracy / Receipt of an Order as Part …
Polish 2.0 KB
2025-11-25 17:41
Regulatory News Service
Zawarcie umowy o dofinansowanie w ramach programu FENG / Conclusion of the co-f…
Polish 1.0 KB
2025-11-25 17:14
Director's Dealing
Powiadomienie 2
Polish 5.2 KB
2025-11-25 17:14
Related Party Transaction
Powiadomienie 1
Polish 5.3 KB
2025-11-25 17:14
Major Shareholding Notification
Zawiadomienia od osoby pełniącej obowiązki zarządcze w Spółce / Notifications f…
Polish 971 bytes
2025-11-21 17:19
Regulatory News Service
Otrzymanie istotnego zlecenia / Receipt of a significant purchase order - Conte…
Polish 1.1 KB
2025-11-21 17:01
Related Party Transaction
19.1.MAR
Polish 4.4 KB
2025-11-21 17:01
Director's Dealing
19.1.MAR
Polish 4.3 KB
2025-11-21 17:01
Major Shareholding Notification
Zawiadomienia od osoby pełniącej obowiązki zarządcze w Spółce / Notifications f…
Polish 952 bytes
2025-11-20 00:02
Quarterly Report
Jednostkowe sprawozdanie finansowe Q3 pdf
Polish 1022.9 KB
2025-11-20 00:02
Quarterly Report
Consolidated Financial Statements Q3 pdf
English 1.1 MB
2025-11-20 00:02
Regulatory News Service
Skonsolidowane sprawozdanie finansowe Q3 pdf
Polish 2.2 MB
2025-11-20 00:02
Quarterly Report
Selvita Capital Group Q3 Report pdf
English 7.9 MB
2025-11-20 00:02
Quarterly Report
Sprawozdanie Zarządu z działalności (Grupa Kapitałowa) Q3 pdf
Polish 8.0 MB

Automate Your Workflow. Get a real-time feed of all Selvita S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Selvita S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Selvita S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Israel
TMIS
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom
TCF
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden
TOL
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France
ALUCR
VERICI DX PLC Logo
AI-powered diagnostic tests for the kidney transplant market, predicting organ rejection and injury.
United Kingdom
VRCI
Vicore Pharma Holding Logo
Develops AT2 receptor drugs and a digital therapeutic for pulmonary fibrosis.
Sweden
VICO
R&D in renewable energy & manufacturing specialized tools for automotive & engineering.
Slovakia
0OCW
Xlife Sciences AG Logo
A life sciences incubator commercializing early-stage academic research for healthcare markets.
Switzerland
XLS
Yoshi Innovation Spolka Akcyjna Logo
A tech fund incubating MedTech, biotech, and defense ventures with investment and IP protection.
Poland
YOS

Talk to a Data Expert

Have a question? We'll get back to you promptly.